Microfluidic Assembly of Lipid Nanoparticles for Delivery of Antisense Oligonucleotides

被引:3
|
作者
Zhou, Yulin [1 ]
Meng, Zhaoli [1 ]
Guo, Tianqi [1 ]
Fu, Yige [1 ]
Lee, Robert J. [1 ]
Xie, Jing [1 ]
机构
[1] Jilin Univ, Sch Life Sci, Changchun 130012, Peoples R China
关键词
Antisense oligonucleotide; cancer; microfluidics; nanoparticles; ribonucleotide reductase; RIBONUCLEOTIDE REDUCTASE; GTI-2501;
D O I
10.2174/1389201015666141020155417
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Microfluidically (MF) synthesized lipid nanoparticles (LNPs) for antisense oligonucleotides (ODN) delivery have been shown to be superior to those prepared by bulk mixing (BM). In this study, a 5-inlet MF chip was used to synthesize LNPs loaded with LOR-2501, an antisense ODN targeting the ribonucleotide reductase R1 subunit. The size distribution of ODN-LNPs was measured by dynamic light scattering. The cytotoxicity of ODN-LNPs was determined by MTS assay. Gene silencing activity of ODN-LNPs was investigated by qRT-PCR and by Western blot. Results showed that MF synthesis produced ODN-LNPs that have lower average size and polydispersity values. The highest antisense activity was shown by LNs synthesized by the MF T2 chip, with downregulation of R1 mRNA by 32.5%. In conclusion, given their simplicity, affordability and reproducibility, MF is an attractive method for synthesis of LNs for ODN delivery.
引用
收藏
页码:823 / 828
页数:6
相关论文
共 50 条
  • [21] Microfluidic hydrodynamic focusing synthesis of polymer-lipid nanoparticles for siRNA delivery
    Huang, Xueqin
    Lee, Robert J.
    Qi, Yuhang
    Li, Yujing
    Lu, Jiahui
    Meng, Qingfan
    Teng, Lesheng
    Xie, Jing
    ONCOTARGET, 2017, 8 (57) : 96826 - 96836
  • [22] Folate receptor-targeted lipid-albumin nanoparticles (F-LAN) for therapeutic delivery of an Akt1 antisense oligonucleotide
    Li, Hong
    Liu, Yang
    Chen, Lihua
    Liu, Qibing
    Qi, Shanshan
    Cheng, Xinwei
    Lee, Young B.
    Ahn, Chang-Ho
    Kim, Deog Joong
    Lee, Robert J.
    JOURNAL OF DRUG TARGETING, 2018, 26 (5-6) : 466 - 473
  • [23] Shock waves: a novel method for cytoplasmic delivery of antisense oligonucleotides
    Tschoep, K
    Hartmann, G
    Jox, R
    Thompson, S
    Eigler, A
    Krug, A
    Erhardt, S
    Adams, G
    Endres, S
    Delius, M
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2001, 79 (5-6): : 306 - 313
  • [24] Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA
    Fattal, Elias
    Bochot, Amelie
    ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (11) : 1203 - 1223
  • [25] Intradermal delivery of antisense oligonucleotides by the pulse depolarization iontophoretic system
    Aramaki, Y
    Arima, H
    Takahashi, M
    Miyazaki, E
    Sakamoto, T
    Tsuchiya, S
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2003, 26 (10) : 1461 - 1466
  • [26] A Covalently Stabilized Lipid-Polycation-DNA (sLPD) Vector for Antisense Oligonucleotide Delivery
    Yang, Xiaojuan
    Peng, Yong
    Yu, Bo
    Yu, Jianhua
    Zhou, Chenguang
    Mao, Yicheng
    Lee, L. James
    Lee, Robert J.
    MOLECULAR PHARMACEUTICS, 2011, 8 (03) : 709 - 715
  • [27] Dendrimer conjugates for light-activated delivery of antisense oligonucleotides
    Yuan, Ahu
    Hu, Yiqiao
    Ming, Xin
    RSC ADVANCES, 2015, 5 (44): : 35195 - 35200
  • [28] Controlled delivery of antisense oligonucleotides: a brief review of current strategies
    Zhao, Xiubo
    Pan, Fang
    Holt, Cathy M.
    Lewis, Andrew L.
    Lu, Jian R.
    EXPERT OPINION ON DRUG DELIVERY, 2009, 6 (07) : 673 - 686
  • [29] Inhibition of the EGFR with nanoparticles encapsulating antisense oligonucleotides of the EGFR enhances radiosensitivity in SCCVII cells
    Ping, Yehui
    Jian, Zou
    Yi, Zhang
    Zhao Huoyu
    Feng, Liu
    Yang Yuqiong
    Liu Shixi
    MEDICAL ONCOLOGY, 2010, 27 (03) : 715 - 721
  • [30] Lipid Nanovesicles in Cancer Treatment: Improving Targeting and Stability of Antisense Oligonucleotides
    Ding, Hui-yan
    Zhou, Han
    Jiang, Yi
    Chen, Si-si
    Wu, Xiao-xia
    Li, Yang
    Luo, Jun
    Zhang, Peng-fei
    Ding, Yi-nan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 1001 - 1023